Relay Therapeutics' Upcoming Engagements
Relay Therapeutics, Inc. (Nasdaq: RLAY), a pioneering clinical-stage precision medicine company, has announced its forthcoming participation in two notable investor conferences scheduled for June. This initiative reflects the company's commitment to engaging with investors and sharing its innovative approach to drug discovery.
Conference Participation Details
The first event is the Jefferies Global Healthcare Conference taking place on June 4. Relay Therapeutics will feature a fireside chat beginning at 8:45 a.m. ET, where company management will share firsthand insights into their evolving strategies and the impact of their work.
Goldman Sachs Global Healthcare Conference
Following the Jefferies event, Relay Therapeutics will participate in the Goldman Sachs Global Healthcare Conference on June 11 at 2:40 p.m. ET. This platform will provide an opportunity for Relay's leadership to engage with a broad audience, highlighting advancements in their drug discovery capabilities.
Webcasts and Accessibility
Both fireside chats will be available for live webcast. Attendees can access the webcasts directly from the Relay Therapeutics website, under the 'Events' section. Additionally, archived versions of these webcasts will be accessible for a period of 30 days after each event, allowing a wider audience to benefit from the insights shared.
About Relay Therapeutics
Relay Therapeutics is dedicated to transforming the drug discovery process through an innovative combination of computational and experimental technologies. By utilizing its proprietary Dynamo® platform, the company seeks to address challenging protein targets in drug development, particularly within oncology and genetic diseases. The focus on small-molecule therapeutic discovery is designed to bring revolutionary therapies to patients in need.
Advancing Drug Discovery
The company's unique approach at the intersection of cutting-edge technology empowers them to navigate and solve complex biochemical challenges. This positions Relay Therapeutics as a leader in creating innovative solutions in the pharmaceutical industry.
To learn more about Relay Therapeutics and stay updated on their progress, visit their official website or follow them on social media channels.
Contact and Media Inquiries
For any inquiries, Pete Rahmer is available for contact at prahmer@relaytx.com. Additionally, for media-related questions, Dan Budwick from 1AB can be reached at 973-271-6085 or via email at dan@1abmedia.com.
Frequently Asked Questions
What events is Relay Therapeutics participating in June?
Relay Therapeutics will participate in the Jefferies Global Healthcare Conference and the Goldman Sachs Global Healthcare Conference.
Where can I access the webcasts of these events?
The webcasts can be accessed on Relay Therapeutics' website under the 'Events' section. Archived replays will be available for 30 days after the events.
What is the focus of Relay Therapeutics?
Relay Therapeutics focuses on transforming drug discovery through a combination of advanced computational and experimental techniques targeting oncology and genetic diseases.
How does Relay Therapeutics aim to impact drug discovery?
By utilizing their Dynamo® platform, Relay Therapeutics seeks to address previously intractable protein targets, aiming to bring life-changing therapies to patients.
Who can I contact for more information?
For inquiries, contact Pete Rahmer at prahmer@relaytx.com or for media questions, reach out to Dan Budwick at dan@1abmedia.com.
